Episodes
Every episode of No Spotlight Needed pulls back the curtain on the decisions, setbacks, and hard-won lessons that define exceptional leadership in healthcare, MedTech, life sciences, and biotech. No talking points. No PR filters. Just real conversations with the people who've done it - and lived to tell the story.
Pick an episode. You won't just listen. You'll learn.
How This Company Went From Nothing To $4 Billion!
Kevin Sayer spent 15 years as CEO of Dexcom, growing it from a niche startup into a $4 billion company that created the continuous glucose monitoring industry from scratch. In this episode of No Spotlight Needed, he sits down...
Perfect Chemistry: The Untold Story Behind the Hepatitis C Cure
What does a career look like when one chapter ends with an $11 billion acquisition, the next involves FBI visits and death threats, and the third ends with a devastating phase 3 failure that nobody saw coming?Dr. Michelle Ber...
What $12 Billion in Biotech Exits Taught This CEO About Relationships…
What does it actually take to build a biotech from nothing... no IP, no programs, no money — into a company acquired by Eli Lilly for over $3 billion? In this episode of No Spotlight Needed, host Sheetal sits down with Pravee...
Former CEO Explains How to Build a Forever Company With Culture That …
Welcome to Season 2 of No Spotlight Needed! Episode 1 features Bruce Cozadd, former CEO of Jazz Pharmaceuticals. Bruce walks through the real moments behind building Jazz into a durable business, including what happened durin...
The $20M to $400M Scaling Blueprint | Dorothy Gemmell Interview
In this Episode of No Spotlight Needed, Sheetal sits down with Dorothy Gemmell, a five time Chief Commercial Officer who helped scale multiple high growth healthcare businesses. Dorothy shares how she went from studying biochemistry at McGill University to pharmaceutical sales, then into leadership…
Building a $14B Lab Business: David King on CEO Development, Decision…
Most people know LabCorp for routine blood work. But under CEO Dave King, the company expanded far beyond basic diagnostics, scaling from about $4B to $14B in revenue while navigating relentless pricing pressure, major acquisitions, and a rapidly changing healthcare landscape.
A CFO’s Playbook for Building Trust, Leading Through Crisis, and Driv…
Many investors and operators call Mettler Toledo one of the best run companies in the world. In season 1, episode #3 of No Spotlight Needed, Sheetal sits down with Bill Donnelly, longtime CFO of Mettler Toledo, to unpack the ...
From Startup Failure to $1.2B Success: Erica Rogers on Culture, Resil…
In Season 1, episode #2 of No Spotlight Needed, host Sheetal Prasad sits down with Erica Rogers, board director and former CEO, to unpack the real story behind building and leading in MedTech, from her early career at Boston ...
4 Time CEO Keith Grossman on Turnarounds, Culture, and Boardroom Trut…
In Episode 1 of Season 1 of No Spotlight Needed, Sheetal sits down with Keith Grossman, a four time CEO and MedTech operator known for building and turning around companies through focus, urgency, and team first culture.Keith...
Introducing No Spotlight Needed, Real Stories of Extraordinary Execut…
Welcome to No Spotlight Needed, a leadership podcast that explores the human stories behind extraordinary executives. Hosted by Sheetal Prasad, an equity investor with 25+ years of experience analyzing business models and ass...
